Recent Updates
Recently added Catalysts
VTRS Positive Sentiment

Viatris to Participate in Upcoming Investor Conferences

Key Takeaway: Viatris Inc. has announced its participation in two upcoming healthcare conferences in December 2025. The company will engage in fireside chats at the Piper Sandler 37th Annual Healthcare Conference and the Evercore 8th Annual Healthcare Conference. Both sessions will be accessible to investors and the public, with archived versions available post-event.
Price reaction · baseline $10.46 (2025-11-21 close) · hit pre-market · clean, no other VTRS news in the window
day 0 close · peak
+1.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in two prominent healthcare conferences.
  • Opportunity for investors to engage with company leadership.
  • Live and archived sessions available for broader audience access.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+38%
120-day peak, hindsight
Typical move
1.6%
average across 12 past catalysts
Lead asset
Mylan's insulin glargine
Phase 3 · Type 1 Diabetes

Full Press Release Details

PITTSBURGH,Nov. 24, 2025/PRNewswire/ --Viatris Inc. (Nasdaq:VTRS), a global healthcare company, today announced that the Company will participate in two upcoming healthcare conferences in December 2025.
The Company will participate in a fireside chat at the Piper Sandler 37thAnnual Healthcare Conference on December 2, 2025, at 8:30 a.m. ET.
In addition, the Company will take part in a fireside chat at the Evercore 8thAnnual Healthcare Conference on December 3, 2025, at 8:45 a.m. ET.
Investors and the general public are invited to listen to both sessions at their respective times atinvestor.viatris.com. An archived version of each session will be available following the live event and can be accessed at the same location for a limited time.

About ViatrisViatris Inc.(Nasdaq:VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more atviatris.comandinvestor.viatris.com, and connect with us onLinkedIn,Instagram,YouTubeandX.

About Viatris Inc.

Ticker Symbol: VTRS
Exchange: NASDAQ
Mission: Empower people worldwide to live healthier at every stage of life
Patient Reach: ~1 billion patients annually
Global Centers: Pittsburgh, Shanghai, Hyderabad

Frequently Asked Questions

When will Viatris participate in the healthcare conferences?

Viatris will participate on December 2 and 3, 2025.

How can the public access the Viatris conference sessions?

The sessions will be available live and archived at investor.viatris.com.

What is the purpose of Viatris's participation in these conferences?

The conferences provide an opportunity for investors to engage with company leadership.

What type of events will Viatris be involved in?

Viatris will participate in fireside chats at the conferences.

Last updated: Nov 24, 2025